Skip to main content
  • Sanofi Genzyme Australia
  • Sanofi Genzyme Global
  • Contact Us
  • My Account
  • Logout
  • Diagnostic Testing
  • Resources
  • Find A Rep
  • Full Menu

Sitemap

  • THERAPY AREAS
    • Fabry Disease
    • Gaucher Disease
    • MPS I & MPS II
    • Pompe Disease
  • RESOURCES
    • Home
    • Legal Notice
    • Privacy Policy
    • Contact Us
  • PRODUCTS
    • Aldurazyme
    • Cerdelga
    • Cerezyme
    • Elaprase
    • Fabrazyme
    • Myozyme
  • Therapy Areas
    • Fabry Disease
    • Gaucher Disease
    • MPS I & MPS II
    • Pompe Disease
  • Resources
    • Tools & Resources
    • Order a Diagnostic Test
  • Products
    • Aldurazyme
    • Cerdelga
    • Cerezyme
    • Elaprase
    • Fabrazyme
    • Myozyme
SIGN UP TO OUR NEWSLETTER

Sanofi Genzyme Online has information to share with you. Sign up to all the news from the team at Sanofi Genyme.
GET IN TOUCH

Please complete this form to contact Sanofi Genzyme with questions or comments.
  • Legal Notice
  • Privacy Policy
  • Sitemap
  • Sanofi Genzyme Australia
  • Contact Us
  • genzyme

This site is intended for Australian Healthcare Professionals only.
© 2020 sanofi-aventis australia pty ltd trading as Sanofi Genzyme ABN 31 008 558 807.
Talavera Corporate Centre. Building D, 12-24 Talavera Road, Macquarie Park, NSW 2113.
MAT-AU-2000597. September 2020

All Results
Articles
Product Sites

Select any filter and click on Apply to see results

Redirecting

You are now leaving https://sanofigenzymeonline.com.au.

Redirecting to

Sanofi Genzyme Australia does not review the information contained on this website and/or database for content, accuracy or completeness. Use of and access to this information is subject to the terms, limitations and conditions set by the website and/or database producer.

Sanofi Genzyme Australia makes no representation as to the accuracy or any other aspect of the information contained on such website and/or database, nor does Sanofi Genzyme Australia necessarily endorse such website and/or database.

Continue

Redirecting

You are now leaving https://sanofigenzymeonline.com.au.

Redirecting to

You are about to visit another Sanofi Genzyme Australia site. This site is governed by Sanofi Genzyme Australia.

Continue

Sign Up

Contact Us

* Mandatory fields

Legal Notice

This page describes the terms and conditions governing the use of this website (hereinafter the "Site").

By visiting the Site you unconditionally undertake to comply with these terms and conditions. As terms and conditions may be amended at any time, without prior notice, we advise you to consult them regularly.

 

1. Intellectual property

The Site belongs to and is operated by sanofi-aventis australia pty ltd trading as Genzyme ABN 31 008 558 807, (hereinafter the “Company”) belonging to the Sanofi Group. The layout and each of the components, including trademarks, logos and domain names, appearing on the Site www.genzymeonline.com.au and associated/pointed sub-domains, are protected by current laws on intellectual property, and belong to the French parent company: SANOFI or its subsidiaries, or their use is the subject of an authorisation.

No component of the Site may be copied, reproduced, altered, edited, downloaded, denatured, transmitted or distributed in any way whatsoever, on any medium whatsoever, in whole or in part, without the prior written consent of the Company, except solely for use for press requirements conditional on compliance with intellectual property rights and any other property rights that are mentioned. Only copying for private use is authorised for your own personal, private, non-commercial use, on your personal computer.

The following statement should appear on any authorised copy of all or part of the content of the Site: "COPYRIGHT 2005-2015 sanofi-aventis australia pty ltd trading as Genzyme – ALL RIGHTS RESERVED".

Any authorised use of items composing or shown on the Site must not be denatured, changed or altered in any way whatsoever. The Company or its subsidiaries reserve the right to take legal action against any breach of its intellectual property rights.

 

2. Nature of information

Information, especially financial, published on the Site shall not be considered as an encouragement to invest. It should not under any circumstances be interpreted as prospecting or as a public offering, nor is it an offer to subscribe, buy or swap shares or other securities in the Company and/or its subsidiaries concerned. The Company draws your attention to the fact that financial information posted on the Site is regularly updated (if financial information is provided on-line).

The Site may offer opinions by experts consulted in a particular field in relation to the content of the Site or excerpts from press articles. Any such information solely represents the opinion of the expert consulted or the publication, and is not necessarily the opinion of the Sanofi Group. Any such experts are not employees of the Sanofi Group and do not receive any emoluments in exchange for the Company using their opinion. The Company is not responsible for the accuracy or completeness of any such information and opinions. Experts’ opinions reflect their own personal views and should never be interpreted as being the opinion or responsibility of the Company and/or SANOFI.

The Site also includes information on health, physical condition, the medical field and medical treatments solely for human use. Said information is published on the Site for information purposes only and is no substitute for the advice of your physician or pharmacist. The information should not be used under any circumstances to make a medical diagnosis of an illness or physical problem, or for prescribing or using drugs presented on the Site. The Site is not intended to be used to report health concerns, adverse events or product technical complaints, or to ask technical or medical questions regarding the Company’s products. In all instances you should refer to your physician or pharmacist.

 

3. Links to other sites

The liability of the Company or of SANOFI shall not be incurred by a third party site that can be accessed via the Site. We do not have any way of controlling the content of such third party sites which remain entirely independent of the Company. Moreover, the existence of a link between the Site and a third party site does not under any circumstances mean that the Company approves the content of that site in any way whatsoever and in particular the use that may be made of it.

In addition, you are responsible for taking the precautions necessary to prevent any infection from the Site, in particular by one or more computer viruses, Trojan horses or any other "parasite".

External sites may include hypertext links to the Site. Any such links should not be created without the express prior consent of the Company. In any case, the Company is not in any way liable for the non-availability of such sites and the Company does not scrutinise, check or approve them and is not responsible for contents, advertising, products or other components available on or via those sites.

 

4. Personal information and other information

4.1 The Company will not disclose to third parties personal data about you that you may convey to it by e-mail. It will only be used with a view to providing you with an answer as effectively as possible. In accordance with local legislation Privacy Act 1988 (Cth), you have the right to access, alter and rectify personal data that concerns you. To do so, request as follows:

E-mail:

privacyofficer.australia@sanofi.com

Mail:

Privacy Officer 
sanofi-aventis australia pty ltd trading as Genzyme 
Talavera Corporate Centre Building D, 12-24 Talavera 
Road Macquarie Park NSW 2113

 

4.2 The Site is intended to receive personal and health information from you. Consequently any information, whatever its from - document, data, graphic, question, suggestion, concept, comment or other - that you send us via the Site, will not under any circumstances be deemed confidential. Consequently, the act of sending it to us alone gives us the right to use it, reproduce it, publish it, alter it or disclose it within the Sanofi Group.

 

5. Limitations on liability

The Company strives to the best of its ability to ensure that information published on the Site is accurate and up-to-date. It reserves the right to correct content at any time, without prior notice. However, the Company cannot guarantee that the information available on the Site is accurate, correct, up-to-date or complete. Consequently, and except for property damage resulting from gross or intentional negligence by the Company, the latter declines any liability:

  • for any inaccuracy, error or omission as regards information available on the Site;
  • for any damage resulting from fraudulent intrusion by a third party resulting in an alteration of information or items made available on the Site; and more broadly
  • for any property damage or consequential loss, for any reason, of any origin, nature or with any consequences whatsoever, even if the Company had been warned of the possibility of such damage or loss, caused (i) because of any access to the Site or because it was impossible to access it, (ii) because of the use of the Site, including any harm or virus that may infect your computer or any other property, and/or (iii) because of the credence given to any information coming directly or indirectly from the Site.

The components of the Site or of any other site are provided "as is" without any guarantee of any kind, whether implicit or explicit. The Company does not offer any implicit or explicit guarantee, relative, without limitation, to their market value or suitability for any given purpose.

 

6. Availability of the web site

You acknowledge (i) that it is technically impossible to provide the Site free from any defect and that the Company cannot undertake to do so; (ii) that defects may lead to the Site being temporarily unavailable; and that (iii) operation of the Site can be affected by events and/or matters that the Company does not control, such, for example, as means of transmission and communication between you and the Company and between the Company and other networks.

The Company and/or its suppliers may, at any time, alter or interrupt, temporarily or permanently, all or part of the Site to undertake maintenance and/or make improvements and/or changes to the Site. The Company is not responsible for any alteration, suspension or interruption of the Site.

 

7. Information on products

Information included and published on the Site may include direct or indirect references to products, programmes and services of the Sanofi Group that are not announced or available in some countries or some regions or that may be supplied under a different name and may be subject to regulations and terms of use that differ depending on the country. Such references do not mean that the Sanofi Group intends to sell those products, programmes or services in your country. Refer to the Company or your Sanofi sales partner for any information about the products, programmes and services available to you.

 

8. Legal provisions

The Site and its content are governed by the Laws of Australia, and any disputes relating thereto are subject to the jurisdiction of the courts of Australia.

 

9. Terms and conditions

9.1 Publisher of the Site:

sanofi-aventis australia pty ltd trading as Genzyme (ABN 31 008 558 807) of Talavera Corporate Centre, Building D, 12-24 Talavera Road, Macquarie Park NSW 2113

 

9.2 Head of Publication:

Head of Communications

 

9.3 Site hosting:

Amazon Webservices AWS.Amazon.com

 

10. Photo / video credits

All images are courtesy of the sanofi-aventis australia pty ltd trading as Genzyme database. Where relevant, all images are reproduced with permission.

Updated: March 04, 2015

 

 

Privacy Statement

sanofi-aventis australia pty ltd trading as Genzyme, (hereinafter “Genzyme”) are bound by the Australian Privacy Principles contained in the Privacy Act 1988 (Cth) for Australia as well as the Privacy Principles contained in the Privacy Act 1993 for New Zealand (together referred to as the “Principles”). The Principles define personal information as information or an opinion relating to an individual which can be used to identify that individual (such as name, address, telephone number, email address), and are designed to protect the confidentiality of personal information and the privacy of individuals by regulating the way personal information is managed.
 
Genzyme recognises the importance of your privacy and understands that the security of your personal information is important to you. We are committed to protecting the personal information you provide to us. This privacy policy outlines how we generally manage your personal information and protect your privacy.
 
This privacy policy (“Privacy Policy” or “Policy”) does not apply to third party online resources to which Genzyme’s website might be linked where Genzyme does not control the privacy practices of such resources. However, Genzyme will endeavour to link to online resources that are known to abide by the Principles.

 

1. Why does Genzyme collect personal information?

Genzyme is a leading Australian company and is part of the international Genzyme Group. Genzyme is in the business of researching, developing, manufacturing and marketing pharmaceutical and rare disease products. As a matter of conducting its routine business, Genzyme may collect the following types of personal information:

a. Websites

When you look at a Genzyme operated website, the Internet Service Provider of our parent company located in France makes a record of your visit and logs the following information for statistical purposes:

  • your server address;
  • your top level domain name (for example .com, .gov, .au, .uk etc);
  • the pages you accessed and documents downloaded;
  • the previous site you have visited; and
  • the type of browser you are using.
Genzyme will only record your e-mail address if you send us a message. Your e-mail address will only be used or disclosed for the purpose for which you have provided it and it will not be added to a mailing list or used or disclosed for any other purpose without your consent.
 
Google Analytics Demographics and Interest Reporting have been enabled on some Genzyme operated websites and as a result personal information about users such as age, gender and interests may be collected. Such information will only be used or disclosed for the purpose of better understanding our users in order to identify how experience and interaction can be improved and tailoring the information which is provided to them.  This personal information will not be used or disclosed for any other purpose without your consent.
 

2. How does Genzyme use personal information and to whom may Genzyme disclose it?

The Principles generally require Genzyme to use personal information only for the primary purpose for which it is collected, or for secondary purposes that are related to the primary purpose.
 
This may include the use of third party software to store, collate and manage your personal information. The third party entities do not have direct access to your personal information. Your personal information will only be used for direct marketing with your consent. You are able to “unsubscribe” from the mailing list and the direct marketing communications at any time by contacting our Privacy Officer. Genzyme’s websites are managed by an external agency, so your personal information will also be disclosed to an external agency to assist with this purpose.
 
Genzyme will use a marketing automation platform to provide automated updates to customers who have opted in to receive communications.  At all times, Genzyme staff will use the Platform in accordance with this Privacy Policy, the Principles and the Spam Act 2003. In compliance with these Acts, Genzyme will not send you a commercial electronic message unless permitted.
 
Your data will be retained by the marketing automation platform for the specific purpose of providing you with tailored communication in accordance with your preferences. This data will be stored and accessed solely for this purpose.

In general, Genzyme uses personal information for the following purposes to:

  • Promote and market Genzyme’s products and services;
  • to provide health products or services (including advice) that have been requested;
  • to involve doctors and investigators (and the people who assist them) in clinical trials; and
  • To comply with legal obligations.
Genzyme discloses personal information to third parties, including its associated Companies, within or outside of Australia or New Zealand, including but not limited to: France, USA, Singapore and Japan to help Genzyme improve its pharmaceutical, consumer healthcare, rare disease, vaccine and animal health products and health services. Information may also be disclosed to regulatory authorities and ethics committees as part of a clinical trial evaluation, monitoring or inspection process. Genzyme will also disclose personal information to its Affiliate in Malaysia for the purposes of processing invoices and accounts.
 
Generally, we require that organisations outside Genzyme who handle or obtain personal information as service providers to Genzyme acknowledge the confidentiality of this information, undertake to respect an individual’s right to privacy and comply with the Principles and this Policy.
 
In most cases, if you do not provide information about yourself which Genzyme has requested, Genzyme may not be able to provide you with the relevant service or information required.

 

3. Sensitive information is subject to greater restrictions

Some personal information collected by Genzyme is considered “sensitive”. Sensitive information which Genzyme may collect includes a person’s state of health and medical history.
 
The Principles require that sensitive information is used and disclosed only for the purposes for which it was provided, or a directly related secondary purpose, unless you agree otherwise or for other specific reasons such as if the use or disclosure of this information is required by law or to prevent a serious and imminent threat to life or health of an individual.

 

4. Spam

Genzyme’s interactions with you are also regulated by the Spam Act 2003 in Australia and the Unsolicited Electronic Messages Act 2007 in New Zealand. In compliance with these Acts, Genzyme will not send you a commercial electronic message to you unless permitted.

 

5. Management and security of personal information

Genzyme has appointed a Privacy Officer to oversee Genzyme’s management of personal information in accordance with this Policy and the Principles.
 
All data that is collected is held electronically on password protected systems. Personal information is only accessible by persons that require access to that information to carry out their work. Genzyme has directed its staff that personal information must be dealt with in accordance with this Policy and kept secure from unauthorised access or disclosure.

 

6. Accessing personal information that Genzyme holds about you

You can, in most cases, access the personal information Genzyme holds about you. If you wish to do so, please contact Genzyme as set out below.

 

7. Updating personal information that Genzyme holds about you

Genzyme endeavours to ensure that the personal information it holds is accurate, complete and up-to-date. Please contact Genzyme if you believe that the information Genzyme holds about you requires changing or becomes out-of-date. Genzyme’s contact details are set out below.

 

8. What if you have an enquiry?

If you have questions about Genzyme, its privacy practices or this Privacy Policy, wish to provide feedback about this Policy, would like to update your personal details held by Genzyme or wish to access personal information held by Genzyme about you, please contact Genzyme using the contact details below. Genzyme will endeavour to act promptly in response to a request.

 

9. How to complain about a privacy breach and how will Genzyme deal with such a complaint?

If you believe that Genzyme has breached the Principles you may complain in writing to our Privacy Officer (see contact details below). Genzyme will respond within thirty (30) days and will use its best endeavour to resolve the issue.

If you are unsatisfied with Genzyme’s answer, you may take your complaint to the Office of the Australian Information Commissioner as detailed on http://www.oaic.gov.au/privacy/privacy-complaints or to the Office of the Privacy Commissioner for New Zealand as detailed on http://www.privacy.org.nz/your-privacy/how-to-complain/.

How to contact us for requests for Genzyme in Australia and New Zealand

E-mail:

privacyofficer.australia@sanofi.com

Mail:

Privacy Officer 
Sanofi-aventis Australia Pty Ltd 
Talavera Corporate Centre 
Building D, 12-24 Talavera Road
Macquarie Park NSW 2113
This Policy is effective from 1 February, 2014

 

  • Resources
    • Tools & Resources
    • Order a Diagnostic Kit
  • Products
    • Aldurazyme
    • Cerdelga
    • Cerezyme
    • Elaprase
    • Fabrazyme
    • Myozyme
  • Therapy Areas
    • Fabry Disease
      • Fabry Disease Overview
        • Clinical Updates
        • Fabry Video Library
      • About Fabry
      • Signs and symptoms
      • Treatment Options
      • Management of the condition
      • Patient Resources
    • Gaucher Disease
      • Gaucher Disease Overview
      • About Gaucher Disease
      • Signs and symptoms
      • Testing and Diagnosis
      • Treatment Options
      • Management of the condition
      • Patient Resources
      • HCP Resources
    • MPS I & MPS II
      • MPS I & MPS II Overview
      • About MPS I & MPS II
      • Signs and symptoms
      • Testing and Diagnosis
      • Treatment Options
      • Management of the condition
      • Patient Resources
    • Pompe Disease
      • Case Study Videos
      • Clinical Insights Videos
      • Pompe Disease Overview
      • Sanofi Genzyme Symposia Videos
      • About Pompe
      • Signs and symptoms
      • Testing and Diagnosis
      • Treatment Options
      • Management of the condition
      • Patient Resources
      • HCP Resources
      • Order a DBS Kit